Table 1.
Baseline clinical characteristics of our population divided according to SHR
| SHR ≤1n = 1,086 | SHR >1n = 1,788 | |
|---|---|---|
| Sex | ||
| Male, n | 494 (45.5) | 801 (44.8) |
| Female, n | 592 (54.5) | 987 (55.2) |
| Age (years) | 55.5 ± 10.3 | 61.2 ± 13.4* |
| BMI (kg/m2) | 28.4 ± 3.5 | 28.3 ± 3.4 |
| Blood pressure | ||
| Systolic (mmHg) | 122.2 ± 10.7 | 122.6 ± 10.8 |
| Diastolic (mmHg) | 79.3 ± 8.2 | 79.9 ± 7.8* |
| Heart rate (bpm) | 75.1 ± 10.3 | 75.3 ± 11.0 |
| Comorbidities | ||
| Dyslipidemia | 353 (32.5) | 640 (35.8) |
| Hypertension | 420 (38.7) | 711 (39.8) |
| Diabetes | 287 (26.4) | 594 (33.2)* |
| Chronic kidney disease | 44 (4.05) | 75 (4.19) |
| Smoking | 328 (30.2) | 536 (30.0) |
| Medications | ||
| ACE inhibitor/ARB | 386 (35.54) | 654 (36.57) |
| Calcium channel blocker | 123 (11.32) | 206 (11.52) |
| β-Blockers | 105 (9.67) | 179 (10.01) |
| Diuretics | 113 (10.4) | 188 (10.5) |
| Statins | 312 (28.73) | 519 (29.02) |
| Oral hypoglycemic agents | 271 (24.9) | 468 (26.17) |
| Insulin | 25 (2.3) | 45 (2.52) |
| Laboratory analyses | ||
| Plasma glucose (mmol/L) | 5.2 ± 0.9 | 9.7 ± 2.8* |
| HbA1c (%) | 6.1 ± 0.7 | 6.2 ± 1.0* |
| Creatinine (mg/dL) | 1.0 ± 0.2 | 1.0 ± 0.2 |
| Total cholesterol (mg/dL) | 182.1 ± 30.2 | 182.3 ± 30.3 |
| HDL cholesterol (mg/dL) | 51.6 ± 15.9 | 52.0 ± 16.0 |
| LDL cholesterol (mg/dL) | 129.3 ± 23.1 | 129.0 ± 23.2 |
Data are means ± SD or n (%). ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker.
*
P < 0.01.